An Anti Apoptosis Study On Mesenchymal Stem Cells With Dioscin

Q. YU,W.Y. FANG,Y.Z. ZOU,N. ZHU
DOI: https://doi.org/10.1016/j.ijcard.2009.09.418
IF: 4.039
2009-01-01
International Journal of Cardiology
Abstract:Objective To evaluate the effects of Dioscin (DIO), a traditional Chinese medicine on apoptosis of MSCS. Methods The cultured MSCS were at random divided into five groups: normal control group, serum deprivation group, serum deprivation with different dose of Dioscin (DIO) intervention groups (4 mg/L, 40 mg/L and 400 mg/L). The cultured cells were deprived serum for 48 h. MSCS apoptosis was assayed with the method of TUNEL. The Bcl-2/Bax protein expressing ratio was detected with immunohistochemical staining by streptavidin-peroxidase. The expression of Bcl-2 and Bax gene was detected with RT-PCR. The positive cells of Bcl-2 and Bax present dark-brown products in the cytoplasm .and calculating protein positive expression index (PEI). Results There was a basement expression of Bcl-2 and Bax in control group. Compared with control group, The PEI of expressing ratio Bcl-2 /Bax cells were significantly higher in the rest groups (p<0.001). DIO pretreatment could increase the expressions ratio of Bcl-2/Bax. The optional effect presented at low dose DIO, and then was moderate dose DIO. The effect promoting Bcl-2/Bax expression by using intervention with low dose and moderate dose DIO was more significant than that of serum deprivation. The highest expression was in low dose DIO, and then moderate dose DIO. Conclusion Pretreatment with DIO decreases the apoptosis of MSCs under ischemia conditions, and increases the expressions ratio of anti-apoptotic gene Bcl-2/ Bax it relevant protein. Pretreatment with low DIO dose has got the best effect of ani-apoptosis.
What problem does this paper attempt to address?